Author(s):
Saidahon Ahmedova, Muzaffar Asrarov, Sobitjon Mirzakulov, Aliaksei Sysa
Email(s):
saidaxon.axmedova@gmail.com
DOI:
10.52711/0974-360X.2026.00579 
Address:
Saidahon Ahmedova1*, Muzaffar Asrarov2, Sobitjon Mirzakulov3, Aliaksei Sysa4
1Department of Human and Animal Physiology, National University of Uzbekistan Named After Mirzo Ulugbek, Tashkent, 100174, Uzbekistan.
2Institute of Biophysics and Biochemistry, National University of Uzbekistan Named After Mirzo Ulugbek, Tashkent 100174, Uzbekistan.
3Department of Human and Animal Physiology, National University of Uzbekistan Named After Mirzo Ulugbek, Tashkent, 100174, Uzbekistan.
4Department of Environmental Chemistry and Biochemistry, A.D. Sakharov International State Environmental Institute, Belarusian State University, Minsk 220070, Belarus.
*Corresponding Author
Published In:
Volume - 19,
Issue - 9,
Year - 2026
ABSTRACT:
Mitochondrial malfunction and energy metabolism disruption in liver pathology, particularly experimental hepatitis, have been the subject of more recent research. The impaired mitochondrial respiration and oxidative phosphorylation associated with hepatotoxic injury have been demonstrated to induce decreased ATP generation and hepatocyte dysfunction. Hence, the restoration of mitochondrial bioenergetics is a crucial goal in experimental as well as clinical hepatology. This study investigated whether plant-based polyphenol extracts can treat mitochondrial respiratory dysfunction in experimental hepatitis. A model of carbon tetrachloride (CCl4)-induced hepatitis was induced in male rats. Polyphenol extracts were administered and evaluated for their impact on mitochondrial function. The performance of mitochondrial respiration, oxidative phosphorylation efficiency, and ATP synthesis were determined by differential centrifugation of isolated liver mitochondria. In experimental hepatitis, the experimental results confirmed significant inhibition of Complex I-dependent respiration and a dramatic decline in mitochondrial respiration. Administration of several polyphenol extracts caused stabilization of the electron transport chain, increased efficiency of oxidative phosphorylation, restoration of mitochondrial respiration, and restoration of ATP production near the control values. It was found that polyphenol extracts not only compensate for the imbalance of mitochondrial respiratory enzymes, but also protect mitochondrial integrity as hepatotoxicity was well described. These findings suggest that the plant-derived polyphenol extracts restore mitochondrial respiration and energy metabolism in experimental hepatitis exerting a hepatoprotective effect. Polyphenol-based correction of mitochondrial dysfunction may represent a promising approach for prevention and therapy of hepatotoxic liver injury.
Cite this article:
Saidahon Ahmedova, Muzaffar Asrarov, Sobitjon Mirzakulov, Aliaksei Sysa. Study of the effects of Polyphenol Extracts on Mitochondrial Energy Metabolism and Functional activity of the Liver in Carbon Tetrachloride–Induced Experimental Hepatitis. Research Journal Pharmacy and Technology. 2026;19(9):4133-0. doi: 10.52711/0974-360X.2026.00579
Cite(Electronic):
Saidahon Ahmedova, Muzaffar Asrarov, Sobitjon Mirzakulov, Aliaksei Sysa. Study of the effects of Polyphenol Extracts on Mitochondrial Energy Metabolism and Functional activity of the Liver in Carbon Tetrachloride–Induced Experimental Hepatitis. Research Journal Pharmacy and Technology. 2026;19(9):4133-0. doi: 10.52711/0974-360X.2026.00579 Available on: https://rjptonline.org/AbstractView.aspx?PID=2026-19-9-25
REFERENCES:
1. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion. 2006; 6(1): 1–28.
2. Grattagliano I, de Bari O, Bernardo TC, et al. Mitochondria in chronic liver disease. Curr Drug Targets. 2012; 13(9): 1127–1141.
3. Mansouri A, Gattolliat CH, Asselah T. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology. 2018;155(3):629–647.
4. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease. Hepatology. 2016;64(1):73–84.
5. Fernandez-Checa JC, Bagnaninchi P, Ye H, et al. Advanced preclinical models for drug-induced liver injury. J Hepatol. 2021; 75(4): 935–959.
6. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther. 1995; 67(1): 101–154.
7. Ozawa T. Genetic and functional changes in mitochondria associated with aging. Physiol Rev. 1997; 77(2): 425–464.
8. Han D, Hanawa N, Saberi B, Kaplowitz N. Role of glutathione redox status in liver injury. Am J Physiol Gastrointest Liver Physiol. 2006; 291(1): G1–G7.
9. Trauner M, Arrese M, Wagner M. Fatty liver and lipotoxicity. Biochim Biophys Acta. 2010;1801(3): 299–310.
10. Genova ML, Castelluccio C, Fato R, et al. Changes in complex I activity in aged rat mitochondria. Biochem J. 1995; 311(1): 105–109.
11. Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014; 24(10): R453–R462.
12. Cichoż-Lach H, Michalak A. Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol. 2014;20(25):8082–8091.
13. Serviddio G, Bellanti F, Vendemiale G. Free radical biology for medicine. Free Radic Biol Med. 2013; 65: 952–968.
14. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009; 417(1): 1–13.
15. Brand MD. Mitochondrial superoxide production sites. Exp Gerontol. 2010; 45(7-8):466–472.
16. Han D, Hanawa N, Saberi B, Kaplowitz N. Hydrogen peroxide sensitizes hepatocytes to apoptosis. Free Radic Biol Med. 2006; 41(4): 627–639.
17. Aon MA, Cortassa S, O’Rourke B. Redox-optimized ROS balance hypothesis. Biochim Biophys Acta. 2010; 1797(6-7): 865–877.
18. Scarpulla RC. Metabolic control of mitochondrial biogenesis. Biochim Biophys Acta. 2011; 1813(7): 1269–1278.
19. Smith RA, Murphy MP. Mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci. 2010; 1201: 96–103.
20. Hallsworth K, Fattakhova G, Hollingsworth KG, et al. Resistance exercise reduces liver fat. Gut. 2011; 60(9): 1278–1283.
21. Gillessen A, Schmidt HH. Silymarin in liver diseases. Adv Ther. 2020;37(4):1279–1301.
22. Ahmed OM, Mohamed TM, Moustafa AH, et al. Quercetin and wound healing in diabetic rats. Biomed Pharmacother. 2018; 101: 58–73.
23. Recknagel RO, Glende EA Jr, Dolak JA, Waller RL. Carbon tetrachloride toxicity mechanisms. Pharmacol Ther. 1989; 43(1): 139–154.
24. Schneider WC, Hogeboom GH. Isolation of cell components by centrifugation. Cancer Res. 1951; 11: 1–22.
25. Almeida AM, Bertoncini CRA, Borecký J, et al. Mitochondrial DNA damage induced by lipid peroxidation. An Acad Bras Cienc. 2006; 78:505–514.
26. Vladimirov YuA, Archakov AI. Lipid peroxidation in biological membranes. Moscow: Nauka; 1972.
27. Li Z, Graham BH. Measurement of mitochondrial oxygen consumption. Methods Mol Biol. 2012; 837: 63–72.
28. Peterson GL. Simplification of protein assay method. Anal Biochem. 1977;83(2):346–356.
29. Avtandilov GG. Medical morphometry. Moscow: Medicina; 1990.
30. Monteiro R, Azevedo I. Chronic inflammation in obesity. Mediators Inflamm. 2010; 2010: 289645.
31. Dianzani M, Barrera G. Lipid peroxidation pathology. In: Alvarez S, Evelson P, editors. Free Radical Pathophysiology. 2008; 19–38.
32. Boveris A. Hippocampal mitochondrial dysfunction in aging. Am J Physiol. 2008; 294: R501–R509.
33. Ebrahimzadeh MA, Nabavi SM, Nabavi SF, et al. Antioxidant activity of mushrooms. Int J Med Mushrooms. 2010; 12(3): 265–272.
34. Andreeva LI, Kozhemyakin LA, Kishkun AA. Determination of lipid peroxides. Laboratornoe Delo. 1988; 11: 41–43.
35. Mandalou P, Spence E, Datta S, Mills PR. Possible toxic hepatitis during HCV treatment. Hepatology. 2013; 58: 352.
36. Chakraborti T, Das S, Mondal M, et al. Oxidant, mitochondrial and calcium interactions. Cell Signal. 1999; 11(2): 77–85.
37. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr. 2005;81(Suppl 1): 215S–217S.
38. Perron NR, Brumaghim JL. Antioxidant mechanisms of polyphenols. Cell Biochem Biophys. 2009; 53(2): 75–100.
39. Hybertson BM, Gao B, Bose SK, McCord JM. Oxidative stress and Nrf2. Mol Aspects Med. 2011;32(4-6):234–246.
40. Movileanu L, Neagoe I, Flonta ML. Quercetin–lipid bilayer interaction. Int J Pharm. 2000; 205(1-2): 135–146.
41. Valero T. Mitochondrial biogenesis approaches. Curr Pharm Des. 2014;20(35):5507–5509.
42. Monteiro R, Azevedo I. Chronic inflammation and metabolic syndrome. Mediators Inflamm. 2010; 2010: 289645.
43. Ebrahimzadeh MA, Nabavi SM, Nabavi SF, et al. Free radical scavenging activities. Int J Med Mushrooms. 2010; 12(3): 265–272.
44. Bjornsson ES. Drug-induced hepatotoxicity. Int J Mol Sci. 2016; 17(2): 224.
45. Kumar R, Singh P, Sharma A. Hepatoprotective activity of herbal formulation against CCl4 induced liver toxicity in rats. Research Journal of Pharmacy and Technology. 2019; 12(6): 2781–2786.
46. Patel V, Mehta D. Protective effect of plant polyphenols on oxidative stress markers in experimental liver injury. Asian Journal of Pharmaceutical Research. 2020; 10(3): 145–150.
47. Verma S, Gupta N. Evaluation of antioxidant and hepatoprotective properties of medicinal plant extract in rats. Research Journal of Pharmacology and Pharmacodynamics. 2018; 10(4): 193–198.
48. Reddy K, Rao M. Effect of herbal antioxidants on mitochondrial dysfunction in chemically induced hepatitis. Research Journal of Pharmacy and Technology. 2021; 14(2): 915–920.
49. Khan A, Siddiqui H. Role of natural polyphenols in restoration of liver mitochondrial enzymes under toxic conditions. Asian Journal of Research in Chemistry. 2019; 12(5): 235–240.
50. Sharma P, Joshi R. Ameliorative effects of plant-derived antioxidants on liver oxidative damage. Research Journal of Pharmaceutical Dosage Forms and Technology. 2020; 12(1): 33–38.
51. Mishra A, Pandey S. Mitochondrial protective effects of herbal extracts in experimental hepatotoxicity. Asian Journal of Pharmaceutical Research and Development. 2021; 9(4): 58–64.
52. Das S, Roy B. Antioxidant modulation of hepatic mitochondria by natural compounds. Research Journal of Pharmacy and Technology. 2018; 11(9): 4021–4026.
53. Iyer P, Kulkarni S. Protective role of polyphenolic compounds against chemical-induced liver damage. Asian Journal of Research in Biological and Pharmaceutical Sciences. 2022; 10(2): 101–107.
54. Ahmed N, Khan M. Effect of herbal polyphenols on oxidative phosphorylation in experimental liver injury. Research Journal of Pharmacology and Pharmacodynamics. 2021; 13(3): 121–127.
55. Ahmedova S, Asrarov M, Mirzakulov S. Effects of Helichrysum maracandicum polyphenols on mitochondrial membrane permeability integrity in a rat model of toxic hepatitis. Bio Web of Conferences. 2026; 228: 02003.